x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Clinician"s Roundtable

Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician"s Roundtable for discussions on a vast range of topics that every medical professional should know about.

science & medicine medicine

All Episodes

00:03:45

The Hidden Respiratory Burden of Obesity:...

Clinician"s Roundtable ·

2026/01/02

Guest: Sujith Cherian MD, FCCP, DAABIP Obesity introduces distinct changes to respiratory physiology that ripple across care settings—from subtle outpatient symptoms to complex ventilatory challenges in the ICU and heightened perioperative risks. Dr. Sujith Cherian explains real-world scenarios and physiologic insights to show how excess weight influences not just lung mechanics, but length of stay, postoperative recovery, and cardiopulmonary complications. Dr. Cherian is an Associate

en

00:02:45

Understanding the Growing Impacts of Obesity on...

Clinician"s Roundtable ·

2026/01/02

Guest: Sujith Cherian MD, FCCP, DAABIP With obesity rates rising to unprecedented levels, clinicians face critical challenges in managing associated complications. Hear from Dr. Sujith Cherian as he explores obesity’s systemic impact, from cardiovascular and infectious risks to medication dosing and hospital care complexities. Dr. Cherian is an Associate Professor in the Divisions of Critical Care, Pulmonary, and Sleep Medicine at University of Texas Health-McGovern Medical

en

00:02:45

MASLD Explained: A Modern Framework for a Multisystem...

Clinician"s Roundtable ·

2026/01/02

Guest: Peter Buch, MD, FACG, AGAF, FACP Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing liver health concern that's closely linked to obesity and other cardiometabolic risk factors, yet it remains underrecognized in clinical practice. That's why Dr. Peter Buch joins us to discuss how emerging perspectives are changing the way we think about metabolic-related liver disease. Dr. Buch is a board-certified clinical gastroenterologist and Associate Professor at

en

00:04:30

From Gut Microbe to Metabolic Modulator: The...

Clinician"s Roundtable ·

2025/12/31

Host: Hallie Blevins, PhD A new preclinical study investigated whether Roseburia hominis, a gut microbe often depleted in individuals with obesity, could play a direct role in regulating metabolism. Learn more as Dr. Hallie Blevins explores these findings and their potential implications for future treatment of obesity and related metabolic disorders in this AudioAbstract.

en

00:11:15

Reconnecting With Patients: A Human-Centered Approach...

Clinician"s Roundtable ·

2025/12/09

Guest: Michael Greenberg, MD Host: Ryan Quigley What does it really mean to humanize medicine? In this candid conversation, Ryan Quigley and Dr. Michael Greenberg explore how clinicians can revive empathy, trust, and emotional connection in patient care, from intentional language shifts to brief yet meaningful moments of authentic connection. Dr. Greenberg is a dermatologist at the Illinois Dermatology Institute.

en

00:10:45

Timely Surgery for Hip Fractures: Addressing...

Clinician"s Roundtable ·

2025/12/05

Host: Steve Jackson, PharmD Guest: Anna Miller, MD Guest: Michael Weaver, MD Timely surgical intervention is critical for reducing mortality and complications in high-risk hip fracture patients. However, anticoagulation therapy often presents barriers to prompt care, requiring careful coordination and clinical judgment. Joining Dr. Steve Jackson to discuss anticoagulant reversal strategies and multidisciplinary approaches for managing high-risk fracture patients are Drs. Anna

en

00:00:00

Improving Survival and Function in Pediatric TK2d...

Clinician"s Roundtable ·

2025/11/19

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Caterina Garone, MD, PhD What if a rare, progressive neuromuscular disease like thymidine kinase 2 deficiency (TK2d) could not only be stabilized, but partially reversed? Based on findings from a pooled analysis of pediatric patients, pyrimidine nucleoside or nucleotide therapy reduced mortality risk up to 95%, with nearly 75% of patients regaining at least one motor milestone. Joining Dr. Charles Turck to explore these survival and

en

00:00:00

Uncovering the Disease Burden of Untreated Pediatric...

Clinician"s Roundtable ·

2025/11/18

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Cristina Domínguez González, MD, PhD How fast does thymidine kinase 2 deficiency (TK2d) progress without intervention? That’s the question explored by the largest dataset to date on untreated pediatric-onset TK2d, and the results reveal a median survival of just 2.6 years from symptom onset. Additionally, more than 80% lost at least one motor milestone, and many experienced escalating care needs, including ventilatory and feeding tube

en

00:00:00

Improving Perioperative Medication Safety with...

Clinician"s Roundtable ·

2025/11/18

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: John B. Hertig, PharmD, MS, CPPS, FASHP, FFIP From minimizing wrong-drug and dosing errors to easing cognitive burden in the OR, ready-to-administer (RTA) medications are enhancing both safety and efficiency in anesthesiology and perioperative care. Join Dr. Charles Turck and Dr. John Hertig as they explore key medication safety challenges, compare FDA-approved versus 503B compounded products, and share strategies for effectively

en

00:00:00

Understanding the Caregiver Burden in TK2 Deficiency:...

Clinician"s Roundtable ·

2025/11/18

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Philip Yeske, PhD Caring for individuals with thymidine kinase 2 (TK2) deficiency can place extraordinary demands on families, yet caregiver experiences are often overlooked in clinical care. To shed light on this burden, a mixed-methods study explored the physical, emotional, and financial impacts on caregivers. Here with Dr. Charles Turck to share the findings and how we can better support these families is Dr. Philip Yeske, the

en

00:00:00

Linking Obesity to Alzheimer’s: The Lipid Signals...

Clinician"s Roundtable ·

2025/10/31

Guest: Stephen Wong, PhD Emerging research suggests that the effects of obesity extend beyond metabolism, reaching the brain in ways that may influence the development of Alzheimer’s disease. Tune in as Dr. Stephen Wong discusses how fat-derived vesicles act as molecular messengers, potentially linking systemic inflammation and lipid imbalance to neurodegenerative changes. Dr. Wong is the John S. Dunn Presidential Distinguished Chair in Biomedical Engineering at Houston Methodist

en

00:00:00

Screening for Prediabetes in Youth with Obesity:...

Clinician"s Roundtable ·

2025/10/30

Host: Ryan Quigley A cross-sectional study in Frontiers in Endocrinology assessed the triglyceride–glucose (TyG) index as a potential screening marker for prediabetes in children and adolescents with obesity. Hear from ReachMD's Ryan Quigley as he discusses the findings from this research and explores how the TyG index could provide an accessible tool for early risk stratification.

en

00:00:00

Obesity and Cancer Screening: National Trends and...

Clinician"s Roundtable ·

2025/10/28

Guest: Vance Albaugh, MD, PhD Emerging data reveal a troubling trend: individuals with higher body mass index are significantly less likely to receive routine cancer screenings, raising urgent concerns about care equity. Join Dr. Vance Albaugh, Assistant Professor of Metabolic Surgery at Pennington Biomedical Research Center and Louisiana State University, as he dives into the findings from this analysis.

en

00:00:00

Real-World Effectiveness of Liraglutide for Obesity:...

Clinician"s Roundtable ·

2025/10/24

Host: Ryan Quigley A large retrospective study across 38 endocrinology clinics in Turkey showed that liraglutide led to meaningful weight loss and metabolic improvements—even at slightly reduced doses. Hear from ReachMD's Ryan Quigley as he reviews recent real-world data on this GLP-1 receptor agonist.

en

00:00:00

Obesity and Respiratory Function: Understanding...

Clinician"s Roundtable ·

2025/10/24

Guest: Sujith Cherian MD, FCCP, DAABIP Obesity impacts how the lungs function in a variety of ways, and understanding these impacts is essential for interpreting pulmonary function tests, identifying restrictive or obstructive patterns, and managing ventilation. Learn more with Dr. Sujith Cherian, who's an Associate Professor in the Divisions of Critical Care, Pulmonary, and Sleep Medicine at University of Texas Health-McGovern Medical School and the Director of Interventional

en

00:00:00

Advancing MPE Diagnosis and Prognosis: Clinical Value...

Clinician"s Roundtable ·

2025/10/23

Guest: David Feller-Kopman, MD Cytology via thoracentesis remains the first-line approach for diagnosing malignant pleural effusion (MPE), yet its sensitivity is limited. leaving many patients undiagnosed or delayed in treatment. In this expert-led discussion, Dr. David Feller-Kopman explores the limitations of current diagnostic methods and the evolving role of biomarkers in enhancing both diagnostic accuracy and prognostic insight. Dr. Feller-Kopman is a Professor of Medicine

en

00:00:00

Navigating Pediatric Obesity: Tools and Strategies...

Clinician"s Roundtable ·

2025/10/20

Guest: Jaime Moore, MD Discussing weight with pediatric patients and families is a nuanced challenge shaped by stigma, culture, and access—but it’s also a vital opportunity for early intervention. Dr. Jaime Moore shares how to build confidence, counter bias, and leverage practical tools and partnerships that support long-term, personalized care. Dr. Moore is an Assistant Professor of Pediatric Nutrition at the University of Colorado Anschutz School of Medicine and part of the

en

00:00:00

Targeting PIK3CA Mutations in HR+/HER2- Breast...

Clinician"s Roundtable ·

2025/10/17

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sarah Sammons, MD About 40 percent of patients with metastatic HR+/HER2- breast cancer have an activating mutation in the PIK3CA gene,1,2 which plays a key role not only in tumor growth, but also in driving resistance to endocrine therapy.3-5 And while there are several FDA-approved PI3K pathway-targeted agents for patients with PIK3CA tumor mutations,6-8 they come with challenges, like modest efficacy and on-pathway effects.9-12

en

00:00:00

Essential Biomarkers for Assessing and Treating IgA...

Clinician"s Roundtable ·

2025/09/10

Host: Gates B. Colbert, MD Guest: Abdallah Geara, MD IgA nephropathy (IgAN) has a decades-long progression that requires careful monitoring of key biomarkers to optimize management. Hematuria, proteinuria, and estimated glomerular filtration rate levels are all critical to tracking the progression of the disease, and understanding how they’re connected can not only improve prognostication but also guide earlier, more targeted interventions to preserve kidney function. Joining Dr

en

00:00:00

IgA Nephropathy Care: A Shift Toward Proactive,...

Clinician"s Roundtable ·

2025/09/10

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jonathan Barratt, MD, PhD Delayed diagnosis and limited treatment options have historically been barriers to optimal management of IgA nephropathy (IgAN), but that paradigm may be shifting. A paper published in Kidney International in April 2025 points out that significant nephron loss often occurs before diagnosis, making early, targeted treatment essential. The paper makes the case for lowering proteinuria thresholds, minimizing

en

391 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事